DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $34.00 at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by Needham & Company LLC from $36.00 to $34.00 in a research report report published on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the medical instruments supplier’s stock.

Other equities research analysts also recently issued reports about the company. The Goldman Sachs Group decreased their price target on DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating for the company in a report on Monday, May 6th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating for the company in a report on Monday, July 22nd. StockNews.com downgraded DENTSPLY SIRONA from a buy rating to a hold rating in a report on Friday, May 3rd. Evercore ISI decreased their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating for the company in a report on Tuesday, July 9th. Finally, Barrington Research reaffirmed an outperform rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $33.44.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $25.49 on Wednesday. The company has a current ratio of 1.33, a quick ratio of 0.97 and a debt-to-equity ratio of 0.57. The firm has a market cap of $5.17 billion, a PE ratio of -57.93, a price-to-earnings-growth ratio of 1.28 and a beta of 1.01. The company’s 50 day simple moving average is $26.18 and its 200-day simple moving average is $30.08. DENTSPLY SIRONA has a 12-month low of $23.94 and a 12-month high of $40.92.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business’s revenue was down 4.3% on a year-over-year basis. During the same quarter last year, the business posted $0.51 earnings per share. As a group, equities analysts predict that DENTSPLY SIRONA will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.51%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier purchased 3,577 shares of the business’s stock in a transaction dated Friday, May 31st. The stock was acquired at an average price of $27.95 per share, with a total value of $99,977.15. Following the purchase, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Norges Bank purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth about $114,207,000. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 30.4% in the 4th quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares during the period. Generation Investment Management LLP increased its stake in shares of DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after acquiring an additional 1,998,012 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of DENTSPLY SIRONA by 21.1% during the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after acquiring an additional 1,419,503 shares during the period. Finally, SG Americas Securities LLC lifted its holdings in shares of DENTSPLY SIRONA by 2,959.1% during the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after acquiring an additional 1,328,525 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.